142 related articles for article (PubMed ID: 32117735)
1. Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment.
Godina C; Ottander E; Tryggvadottir H; Borgquist S; Isaksson K; Jernström H
Front Oncol; 2020; 10():80. PubMed ID: 32117735
[TBL] [Abstract][Full Text] [Related]
2. Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.
Obi N; Heinz J; Seibold P; Vrieling A; Rudolph A; Chang-Claude J; Berger J; Flesch-Janys D
Int J Cancer; 2016 May; 138(9):2098-108. PubMed ID: 26649645
[TBL] [Abstract][Full Text] [Related]
3. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study.
Tryggvadottir H; Sandén E; Björner S; Bressan A; Ygland Rödström M; Khazaei S; Edwards DP; Nodin B; Jirström K; Isaksson K; Borgquist S; Jernström H
Front Oncol; 2021; 11():642768. PubMed ID: 34094928
[TBL] [Abstract][Full Text] [Related]
5. Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer.
Björner S; Rosendahl AH; Simonsson M; Markkula A; Jirström K; Borgquist S; Rose C; Ingvar C; Jernström H
Front Endocrinol (Lausanne); 2017; 8():332. PubMed ID: 29234306
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.
Klintman M; Rosendahl AH; Randeris B; Eriksson M; Czene K; Hall P; Borgquist S
Breast Cancer Res Treat; 2022 Nov; 196(1):185-196. PubMed ID: 36040641
[TBL] [Abstract][Full Text] [Related]
7. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
Clin Cancer Res; 2017 Feb; 23(3):766-777. PubMed ID: 27810901
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
[TBL] [Abstract][Full Text] [Related]
10. Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment.
Björner S; Rosendahl AH; Tryggvadottir H; Simonsson M; Jirström K; Borgquist S; Rose C; Ingvar C; Jernström H
Front Endocrinol (Lausanne); 2018; 9():306. PubMed ID: 29928262
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
[TBL] [Abstract][Full Text] [Related]
13.
Freitas-Alves DR; Vieira-Monteiro HA; Piranda DN; Sobral-Leite M; da Silva TSL; Bergmann A; Valença SS; Perini JA; Vianna-Jorge R
Endocr Relat Cancer; 2018 Mar; 25(3):351-365. PubMed ID: 29321183
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
15. Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
Leventea E; Harkness EF; Brentnall AR; Howell A; Evans DG; Harvie M
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072619
[TBL] [Abstract][Full Text] [Related]
16. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
[TBL] [Abstract][Full Text] [Related]
17. Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study.
Dackus GMHE; Jóźwiak K; Sonke GS; van der Wall E; van Diest PJ; Hauptmann M; Siesling S; Linn SC
Eur J Cancer; 2018 Feb; 90():92-101. PubMed ID: 29274928
[TBL] [Abstract][Full Text] [Related]
18. CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.
Simonsson M; Veerla S; Markkula A; Rose C; Ingvar C; Jernström H
BMC Cancer; 2016 Mar; 16():256. PubMed ID: 27029552
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
